Alexander Perhal

Alexander Perhal is a Postdoctoral Researcher at the University of Vienna in the Faculty of Life Sciences, Department of Pharmaceutical Sciences, Division of Pharmacognosy. He works in room 2G 449 and can be contacted at +43-1-4277-55239.

Dr. Perhal's research focuses on molecular pharmacology, particularly on GPCR and nuclear receptor signaling pathways. His work centers on identifying novel bioactive natural products and elucidating their molecular targets and cellular signaling pathways using in vitro cell cultures. He specializes in GPCR pharmacology (including cAMP and beta-arrestin signaling) and investigates anti-inflammatory and immune-modulatory compounds with emphasis on immune cell-specific receptors such as nuclear receptors (RORγ), GPCRs (TGR5, GPR84), and enzymes (PDE4).

His publication record shows a strong focus on receptor pharmacology, particularly TGR5 and RORγ receptors, with recent work published in journals like Journal of Natural Products and European Journal of Medicinal Chemistry. His research demonstrates a consistent trajectory in natural product-derived compounds for therapeutic applications.

Dr. Perhal is a member of the Deutsche Gesellschaft für Experimentische und Klinische Pharmakologie und Toxikologie e. V. (DGPT) and maintains scholarly profiles on PubMed, Google Scholar, u:cris, and ORCID.

He teaches Biochemistry and Immunology (B10) and Laboratory Course in Microbiology (B17) at the university level.